Joseph L. Falkson

Dr. Falkson is a co-founder of NAC and manages all aspects of its day-to-day operations.  He leads NAC’s tribal financial services consulting practice; specifically, linking tribes to Federal financing programs such as the Community Development Financial Institutions Fund of the US Department of the Treasury.  Dr. Falkson worked closely with the Lower Brule Corporation (LBC) to form and organize Lower Brule Community Development Enterprise, LLC (LBCDE). He guided LBCDE through the Federal ‘CDFI’ and ‘CDE’ certification processes and continues to guide a variety of its financing and business development activities in support of LBC.  Dr. Falkson works with tribes and tribal consortia on major, large-scale business ventures.  He established Native American Pharmaceuticals (NARx), with PharMerica as an investor and McKesson Corporation as a strategic partner. NARx served as the U.S. Indian Health Service’s prime vendor for the IHS southwest region. He served as a consultant to and board of directors’ member of PharMerica, Inc., a billion-dollar, publicly traded, institutional prescription drug distributor, acquired by Bergen Brunswig Corporation in 1999.  Earlier in his career, Dr. Falkson held three senior public policy positions with the U.S. Government. During the Carter Administration, he was appointed a Public Health Service Fellow and served as senior advisor on HMO policy in the office of the assistant secretary for Health, U.S. Department of Health & Human Services (HHS).  He also served as a special assistant for health policy in the office of the secretary, U.S. Department of Health, Education, and Welfare (HEW). While a graduate student, Dr. Falkson received a White House appointment to serve on the research staff of the President’s National Commission on Urban Problems.  Dr. Falkson earned an MBA from the Wharton School of the University of Pennsylvania; a Ph.D. in political science from the University of Michigan— Ann Arbor; and a B.A. in politics from Brandeis University.